Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors

Biological, clinical, and ethical advances of placebo effects

(2010) Damien G Finniss et al.   LANCET

Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR

(2010) Dean F. Wong et al.   NEUROIMAGE

Mechanisms of Non-Opioid Analgesics Beyond Cyclooxygenase Enzyme Inhibition

(2010) May Hamza et al.   Current Molecular Pharmacology

Dissection of placebo analgesia in mice: the conditions for activation of opioid and non-opioid systems

(2009) J-Y. Guo et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Direct Evidence for Spinal Cord Involvement in Placebo Analgesia

(2009) F. Eippert et al.   SCIENCE

Lipid Mediators in Health and Disease: Enzymes and Receptors as Therapeutic Targets for the Regulation of Immunity and Inflammation

(2008) Takao Shimizu   Annual Review of Pharmacology and Toxicology

Non-redundant Functions of Cyclooxygenases: Oxygenation of Endocannabinoids

(2008) Carol A. Rouzer et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

New Insights into the Placebo and Nocebo Responses

(2008) Paul Enck et al.   NEURON

Mechanisms of Placebo and Placebo-Related Effects Across Diseases and Treatments

(2007) Fabrizio Benedetti   Annual Review of Pharmacology and Toxicology

A Comprehensive Review of the Placebo Effect: Recent Advances and Current Thought

(2007) Donald D. Price et al.   Annual Review of Psychology

The contribution of cyclooxygenase-2 to endocannabinoid metabolism and action

(2007) C J Fowler   BRITISH JOURNAL OF PHARMACOLOGY